157 related articles for article (PubMed ID: 15899827)
1. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins.
Magnon C; Galaup A; Mullan B; Rouffiac V; Bouquet C; Bidart JM; Griscelli F; Opolon P; Perricaudet M
Cancer Res; 2005 May; 65(10):4353-61. PubMed ID: 15899827
[TBL] [Abstract][Full Text] [Related]
2. Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment.
Magnon C; Opolon P; Connault E; Mir LM; Perricaudet M; Martel-Renoir D
Gene Ther; 2008 Nov; 15(21):1436-45. PubMed ID: 18548116
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
4. Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells.
Bellahcène A; Chaplet M; Bonjean K; Castronovo V
Endothelium; 2007; 14(2):123-30. PubMed ID: 17497369
[TBL] [Abstract][Full Text] [Related]
5. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
He GA; Luo JX; Zhang TY; Wang FY; Li RF
Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
[TBL] [Abstract][Full Text] [Related]
6. Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch.
Magnon C; Opolon P; Ricard M; Connault E; Ardouin P; Galaup A; Métivier D; Bidart JM; Germain S; Perricaudet M; Schlumberger M
J Clin Invest; 2007 Jul; 117(7):1844-55. PubMed ID: 17557121
[TBL] [Abstract][Full Text] [Related]
7. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
8. Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin.
Milner R
Glia; 2009 May; 57(7):714-23. PubMed ID: 18985734
[TBL] [Abstract][Full Text] [Related]
9. Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survival.
Bieler G; Hasmim M; Monnier Y; Imaizumi N; Ameyar M; Bamat J; Ponsonnet L; Chouaib S; Grell M; Goodman SL; Lejeune F; Rüegg C
Oncogene; 2007 Aug; 26(39):5722-32. PubMed ID: 17369858
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
11. Cell surface overexpression of alphavbeta5 integrin impedes alphavbeta3-mediated migration of the human ovarian adenocarcinoma cell line IGROV1.
Maubant S; Leroy-Dudal J; Carreiras F; Deslandes E; Duigou F; Staedel C; Gauduchon P
Cell Biol Int; 2007 Feb; 31(2):109-18. PubMed ID: 17074516
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.
Wu LQ; Zhang WJ; Niu JX; Ye LY; Yang ZH; Grau GE; Lou JN
J Vasc Res; 2008; 45(1):78-86. PubMed ID: 17901709
[TBL] [Abstract][Full Text] [Related]
13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
14. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
15. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
Akakura N; Hoogland C; Takada YK; Saegusa J; Ye X; Liu FT; Cheung AT; Takada Y
Cancer Res; 2006 Oct; 66(19):9691-7. PubMed ID: 17018627
[TBL] [Abstract][Full Text] [Related]
16. [Tumor cell-tumor endothelial cell adhesion mediated by alphavbeta3 and alphavbeta5 molecules].
Niu JX; Zhang WJ; Ye LY; Wu LQ; Yang ZH; Zhu GJ; Lou JN
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):165-9. PubMed ID: 18756928
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
18. [In vivo antitumor effect of canstatin gene on human esophageal carcinoma xenografts in nude mice].
Zheng XW; Li Y; Tang FA; Ma J; Zheng PY; Lu GF
Ai Zheng; 2009 Apr; 28(4):350-5. PubMed ID: 19622292
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis.
Veitonmäki N; Cao R; Wu LH; Moser TL; Li B; Pizzo SV; Zhivotovsky B; Cao Y
Cancer Res; 2004 May; 64(10):3679-86. PubMed ID: 15150128
[TBL] [Abstract][Full Text] [Related]
20. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
